BCTRIMS 2023
  1. Home

Program

Filter activities
Aluizio Marques Ballroom
13:30 - 14:00 Opening

Opening Session

Aluizio Marques Ballroom
14:00 - 15:40 Symposium

Política de Saúde em Doenças Desmielinizantes do Sistema Nervoso Central

14:00 - 14:20
A Visão da CONITEC
14:20 - 14:25
Discussão
14:25 - 14:45
Acesso ao Tratamento de Doenças Raras no Brasil
14:45 - 14:50
Discussão
14:50 - 15:10
O Direito do Paciente no Brasil
15:10 - 15:15
Discussão
15:15 - 15:35
A Visão do Médico Especialista
15:35 - 15:40
Discussão
Aluizio Marques Ballroom
15:40 - 16:10 Break

Break

Aluizio Marques Ballroom
16:10 - 17:50 Symposium

Pediatric Neuroimmunology

16:10 - 16:30
Autoimmune encephalitis in children
16:30 - 16:35
Discussion
16:35 - 16:55
NMOSD in children - Update in Treatment and Neuroimaging
16:55 - 17:00
Discussion
17:00 - 17:20
Timing of high-efficacy therapies for pediatric patients with multiple sclerosis
17:20 - 17:25
Discussion
17:25 - 17:45
How safe are MS drugs in children?
17:45 - 17:50
Discussion
Aluizio Marques Ballroom
17:50 - 18:00 Break

Break

Aluizio Marques Ballroom
18:00 - 19:00 Pharma Symposium

Pharma Symposium - ROCHE: Escutando a progressão silenciosa: Perspectivas sobre como lidar com as incapacidades desde o início da EM

Aluizio Marques Ballroom
19:00 - 20:00 Symposium

Neuroimunobol

19:00 - 19:30
Time Vencedor 2022
19:30 - 20:00
Time Desafiante 2023
Aluizio Marques Ballroom
07:30 - 08:00 Lecture

Meeting The Expert

Aluizio Marques Ballroom
08:00 - 10:30 Session

CTRIMS Session

08:00 - 08:20
New diagnostic criteria for MOGAD
08:20 - 08:25
Discussion
08:25 - 08:45
The role of the choroid plexuses in MS: Neuroimaging contribution
08:45 - 08:50
Discussion
08:50 - 09:10
Tuberculosis in multiple sclerosis patients
09:10 - 09:15
Discussion
09:15 - 09:35
Disease Characteristics of Latinx patients using quantitative multi-center data approaches
09:35 - 09:40
Discussion
09:40 - 10:00
Environmental risk factors for MS
10:00 - 10:05
Discussion
10:05 - 10:25
Pathophysiology of NMOSD revisited
10:25 - 10:30
Discussion
Aluizio Marques Ballroom
10:30 - 11:00 Break

Arena Científica ALEXION: Jornada do paciente com NMOSD no Brasil - passado, presente e futuro

Aluizio Marques Ballroom
11:00 - 12:00 Lecture

Aluizio Marques Lecture

11:15 - 12:00
Gaps in the understanding of MS etiopathogenesis
Aluizio Marques Ballroom
12:00 - 13:00 Pharma Symposium

Pharma Symposium - BIOGEN: Cognição e janela de oportunidade terapêutica

Aluizio Marques Ballroom
13:00 - 14:00 Pharma Symposium

Pharma Symposium - NOVARTIS: Listening to the Expert: ofatumumab in clinical practice

13:00 - 13:30
High-efficacy treatment early: challenging the status quo
13:30 - 14:00
Experience: the benefit-risk profile of ofatumumab
Aluizio Marques Ballroom
14:00 - 15:45 Symposium

Emerging Topics in Multiple Sclerosis

14:00 - 14:20
Deep grey matter injury in multiple sclerosis
14:20 - 14:25
Discussion
14:25 - 14:45
New Trends in MS: Remyelination
14:45 - 14:50
Discussion
14:50 - 15:10
Will EBV infection prevention be enough to prevent MS?
15:10 - 15:15
Discussion
15:15 - 15:25
Platform presentation 1 - Reliability of telemedicine evaluation for EDSS functional systems in multiple sclerosis. - Presenter: Cássia Elisa Marin
15:25 - 15:30
Discussion
15:30 - 15:40
Platform presentation 2 - Plasma Neurofilament Light Chain in relapsing remitting multiple sclerosis patients: a new NEDA parameter? - Presenter: Larissa Araujo Duarte
15:40 - 15:45
Discussion
Aluizio Marques Ballroom
15:45 - 16:15 Break

Break

Aluizio Marques Ballroom
16:15 - 18:00 Symposium

Hot Topics in Multiple Sclerosis

16:15 - 16:35
Markers of disease progression in MS
16:35 - 16:40
Discussion
16:40 - 17:00
How does MS affect aging?
17:00 - 17:05
Discussion
17:05 - 17:25
MS treatment dilemma: High efficacy therapies from onset or escalation therapy?
17:25 - 17:30
Discussion
17:30 - 17:40
Platform presentation 3 - Cost comparison between early intensive and escalating strategies for multiple sclerosis in Brazil - Presenter: Leonardo Zumerkorn Pipek
17:40 - 17:45
Discussion
17:45 - 17:55
Platform presentation 4 - REal-world effectiveness and safety of nataLIzumab in relApsing-remittiNg multiple sClerosis Brazilian patiEnts – RELIANCE study - Presenter: Maria Fernanda Mendes
17:55 - 18:00
Discussion
Aluizio Marques Ballroom
18:00 - 19:00 Pharma Symposium

Pharma Symposium - SANOFI: Multicenter Experience : Efficacy & Safety on Alemtuzumab usage

Arena Científica
19:00 - 20:00 Happy Poster

Happy Poster

19:00 - 19:10
Increased production of anti-inflammatory molecules by a B cell subset of Multiple Sclerosis patients treated with Natalizumab - Presenter: Amanda Dias da Rocha Lima
19:10 - 19:20
Senescent-like phenotype of CD8+ T lymphocytes during AQP4-positive NMOSD treated with Rituximab: Reassessing the similarity between NMOSD and MS? - Presenter: Vinícius Oliveira Boldrini
19:20 - 19:30
Leber's Optic Neuropathy and Differential Diagnosis of Atypical Optic Neuritis - Presenter: Karoline Miari Scalioni Cohen
19:30 - 19:40
IS THE MODIFIED FATIGUE IMPACT SCALE APPLIED BY TELEPHONE IN INDIVIDUALS WITH MULTIPLE SCLEROSIS VALID AND RELIABLE? An investigation of measurement properties - Presenter: Juliana Machado Santos Santiago-Amaral
19:40 - 19:50
Real-world application of 2022 diagnosis criteria and proposed classification of optic neuritis - Presenter: Sara Terrim
19:50 - 20:00
Frequency of latent tuberculosis in patients with multiple sclerosis screened for the prescription of alemtuzumab - Presenter: Flavio Vieira Marques Filho
Aluizio Marques Ballroom
07:30 - 08:00 Lecture

Meeting the Expert

Aluizio Marques Ballroom
08:00 - 10:00 Session

Top 10 of the Year: How these Papers Impact our Practice

08:00 - 10:00
Discussion
Aluizio Marques Ballroom
10:00 - 10:30 Break

Break

Aluizio Marques Ballroom
10:30 - 12:35 Symposium

ECF Symposium - Understanding and Measuring Progression

10:30 - 10:50
Pathophysiological mechanisms of progression
10:50 - 10:55
Discussion
10:55 - 11:15
A critical view of silent progression
11:15 - 11:20
Discussion
11:20 - 11:40
Functional assessment of progression
11:40 - 11:45
Discussion
11:45 - 12:05
Role of brain MRI
12:05 - 12:10
Discussion
12:10 - 12:30
The role of PET in monitoring progressive MS
12:30 - 12:35
Discussion
Aluizio Marques Ballroom
12:35 - 13:35 Pharma Symposium

Pharma Symposium - MERCK: Mavenclad® e o tempo: como o early-use e o manejo adequado a longo prazo influenciam a evolução da esclerose múltipla

Aluizio Marques Ballroom
13:35 - 14:35 Pharma Symposium

Pharma Symposium - ALEXION: Do Sistema complemento ao Surto

Aluizio Marques Ballroom
14:35 - 16:45 Symposium

Current questions in NMOSD

14:35 - 14:55
What are the present trends in NMOSD research?
14:55 - 15:00
Discussion
15:00 - 15:20
Treating MOGAD: recent past, present and future
15:20 - 15:25
Discussion
15:25 - 15:45
How specific is NMOSD-optic neuritis?
15:25 - 15:45
How specific are MRI signs in the differential diagnosis between MS, NMOSD, and MOGAD?
15:45 - 16:15
Discussion
16:15 - 16:25
Platform presentation 5 - MOG-IgA characterizes a subgroup of patients with central nervous system demyelination - Presenter: Ana Beatriz Ayroza Galvão Ribeiro
16:25 - 16:30
Discussion
16:30 - 16:40
Platform presentation 6 - Inebilizumab Reduces Attack Risk Independent of Low Affinity IgG Fc Region Receptor III-A Gene Polymorphisms in Neuromyelitis Optica Spectrum Disorder - Presenter: Mariana Graf
16:40 - 16:45
Discussion
Aluizio Marques Ballroom
16:45 - 17:15 Break

Arena Científica Merck: MS no mundo real

Aluizio Marques Ballroom
17:15 - 19:00 Symposium

Issues in NMOSD

17:15 - 17:35
Biomarkers of severity in NMOSD
17:35 - 17:40
Discussion
17:40 - 18:00
Are VEPs and OCT helpful to predict outcome in MS, NMOSD and MOGAD?
18:00 - 18:05
Discussion
18:05 - 18:25
Pregnancy in NMOSD
18:25 - 18:30
Discussion
18:30 - 18:40
Platform presentation 7 - NMOSD leads to unemployment in high educational level people with NMOSD (pwNMOSD): results of an online survey with 146 NMOSD patients. - Presenter: Raquel Vassão Araujo
18:40 - 18:45
Discussion
18:45 - 18:55
Platform presentation 8 - Silent Progressive Brain Atrophy in Clinically Stable Neuromyelitis Optica A Comparative Proof-of-Concept Study - Presenter: Gustavo Medeiros Andrade Figueira
18:55 - 19:00
Discussion
Aluizio Marques Ballroom
07:30 - 08:00 Lecture

Meeting the Expert

Aluizio Marques Ballroom
08:00 - 09:40 Symposium

Harvard Symposium

08:00 - 08:25
Risk and treatment of Vitamin D deficiency in people living with MS
08:25 - 08:30
Discussion
08:30 - 08:55
The spectrum of NMO and MOGAD: lessons I learned
08:55 - 09:00
Discussion
09:00 - 09:15
 Clinical Pearls in MS differential diagnosis
09:15 - 09:20
Discussion
09:20 - 09:35
Differential diagnosis for NMO
09:35 - 09:40
Discussion
Aluizio Marques Ballroom
09:40 - 10:40 Pharma Symposium

Pharma Symposium - HORIZON: Inebilizumab: CD19 As a New Target in B Cell Depletion

Aluizio Marques Ballroom
10:40 - 12:20 Symposium

BCTRIMS NeuroImaging Symposium

10:40 - 11:00
Central vein sign, iron rim and Optic nerve lesions in the diagnostics and prognostic of multiple sclerosis
11:00 - 11:05
Discussion
11:05 - 11:25
Smouldering lesions in MS
11:25 - 11:30
Discussion
11:30 - 11:50
Periventricular gradient in multiple sclerosis
11:50 - 11:55
Discussion
11:55 - 12:15
Differential radiological diagnosis of longitudinally extensive transverse myelopathies
12:15 - 12:20
Discussion
Aluizio Marques Ballroom
12:20 - 13:10 Symposium

BCTRIMS NeuroImaging Symposium – Clinical-Imaging Case Presentations

12:20 - 12:40
Correlating clinical data and imaging to diagnosis multiple sclerosis
12:40 - 12:45
Discussion
12:45 - 13:05
Follow-up in demyelinating diseases of the CNS: What`s the best shot?
13:05 - 13:10
Discussion
Aluizio Marques Ballroom
13:10 - 14:00 Closing Session

Closing Session

Aluizio Marques Ballroom
14:00 - 15:40 Symposium

Simpósio Multiprofissional I

14:00 - 14:20
Unidades de Tratamento de Esclerose Múltipla: conhecendo esse conceito
14:20 - 14:40
A Equipe Multi e os Critérios atuais para o diagnóstico da Esclerose Múltipla
14:40 - 15:00
O que são NMOSD e MOGAD e qual sua relação com EM?
15:00 - 15:20
O que a equipe multiprofissional precisa saber sobre o tratamento medicamentoso da EM?
15:20 - 15:40
Discussão
Aluizio Marques Ballroom
15:40 - 16:00 Break

Break

Aluizio Marques Ballroom
16:00 - 17:40 Symposium

Simpósio Multiprofissional II

16:00 - 16:20
Quando o comprometimento cognitivo desafia o atendimento de enfermagem
16:20 - 16:40
Avaliação Nutricional em pessoas com EM
16:40 - 17:00
Abordagem fisioterapêutica em pessoas com EM
17:00 - 17:20
Abordagem multiprofissional de pacientes com EM: foco em estilo de vida
17:20 - 17:40
Discussão